A citation-based method for searching scientific literature

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.
Karan Seegobin, Umair Majeed, Nathaniel Wiest, Rami Manochakian, Yanyan Lou, Yujie Zhao. Front Oncol 2021
Times Cited: 1



Distribution of PD-L1 expression and its relationship with clinicopathological variables: an audit from 1071 cases of surgically resected non-small cell lung cancer.
Qian Chen, Yi-Yun Fu, Qiao-Ni Yue, Qian Wu, Yuan Tang, Wei-Ya Wang, Yong-Sheng Wang, Li-Li Jiang. Int J Clin Exp Pathol 2019
Times Cited: 12




List of shared articles



Times cited

An advanced non-small cell lung cancer patient with EGFR and KRAS mutations, and PD-L1 positive, benefited from immunotherapy: a case report.
Ronghua Yang, Dong Wang, Xia Li, Kaiping Mao, Jinglong Wang, Peng Li, Xiaoliang Shi, Shanshan Zhang, Yongjie Wang. Ann Transl Med 2022
0


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy